What is Planatome?
Founded in 2017 and headquartered in Phoenix, Arizona, Planatome specializes in advanced scalpel blade technology. The company's core mission is to enhance the performance of existing medical tools and technologies, thereby delivering tangible benefits across the healthcare spectrum. Planatome's innovative approach positions it as a key player in the medical device sector, focused on incremental yet impactful improvements to surgical instruments.
How much funding has Planatome raised?
Planatome has raised a total of $6M across 2 funding rounds:
Debt
$1M
Series A
$5M
Debt (2023): $1M, investors not publicly disclosed
Series A (2023): $5M, investors not publicly disclosed
What's next for Planatome?
With the recent influx of major strategic investment, Planatome is poised for an accelerated phase of growth and innovation. This enterprise-level capital infusion is likely to be directed towards scaling manufacturing capabilities, expanding research and development efforts for next-generation surgical tools, and broadening its market reach. The company's focus on perfecting established technologies suggests a strategy aimed at capturing significant market share through superior product performance and reliability, potentially leading to further strategic partnerships or acquisitions in the medtech industry.
See full Planatome company page
